For: | Koseoglu E. New treatment modalities in Alzheimer's disease. World J Clin Cases 2019; 7(14): 1764-1774 [PMID: 31417922 DOI: 10.12998/wjcc.v7.i14.1764] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v7/i14/1764.htm |
Number | Citing Articles |
1 |
Hitaansh Dhingra, Sonali G Choudhari. Alzheimer’s Disease: Understanding Its Novel Drug Delivery Systems and Treatments. Cureus 2022; doi: 10.7759/cureus.31394
|
2 |
Rohit Malik, Sunishtha Kalra, Saurabh Bhatia, Ahmed Al Harrasi, Govind Singh, Syam Mohan, Hafiz A. Makeen, Mohammed Albratty, Abdulkarim Meraya, Bojlul Bahar, Murtaza M. Tambuwala. Overview of therapeutic targets in management of dementia. Biomedicine & Pharmacotherapy 2022; 152: 113168 doi: 10.1016/j.biopha.2022.113168
|
3 |
Golaleh Ghotbi, Mohammad Mahdavi, Zahra Najafi, Farshad Homayouni Moghadam, Maryam Hamzeh-Mivehroud, Soodabeh Davaran, Siavoush Dastmalchi. Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer’s disease. Bioorganic Chemistry 2020; 103: 104186 doi: 10.1016/j.bioorg.2020.104186
|
4 |
Julio Rodríguez-Lavado, Carlos Gallardo-Garrido, Michael Mallea, Victor Bustos, Rodrigo Osorio, Martín Hödar-Salazar, Hery Chung, Ramiro Araya-Maturana, Marcos Lorca, C. David Pessoa-Mahana, Jaime Mella-Raipán, Claudio Saitz, Pablo Jaque, Miguel Reyes-Parada, Patricio Iturriaga-Vásquez, Hernán Pessoa-Mahana. Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer’s disease. European Journal of Medicinal Chemistry 2020; 198: 112368 doi: 10.1016/j.ejmech.2020.112368
|
5 |
Valery M. Dembitsky, Tatyana A. Gloriozova, Vladimir V. Poroikov. Pharmacological profile of natural and synthetic compounds with rigid adamantane-based scaffolds as potential agents for the treatment of neurodegenerative diseases. Biochemical and Biophysical Research Communications 2020; 529(4): 1225 doi: 10.1016/j.bbrc.2020.06.123
|
6 |
Olga V. Nevzglyadova, Ekaterina V. Mikhailova, Tonu R. Soidla. Yeast red pigment, protein aggregates, and amyloidoses: a review. Cell and Tissue Research 2022; 388(2): 211 doi: 10.1007/s00441-022-03609-w
|
7 |
Jigyasha Timsina, Muhammad Ali, Anh Do, Lihua Wang, Daniel Western, Yun Ju Sung, Carlos Cruchaga. Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification. Neurobiology of Disease 2024; 190: 106373 doi: 10.1016/j.nbd.2023.106373
|
8 |
A. D. Slobodina, O. I. Bolshakova, A. E. Komissarov, N. V. Surina, S. B. Landa, P. A. Melent’ev, S. V. Sarantseva. Study of the Neuroprotective Properties of Fullerenol C60(OH)30 with a Model of Alzheimer’s Disease. Nanotechnologies in Russia 2020; 15(2): 212 doi: 10.1134/S1995078020020184
|
9 |
Zhiyuan Zhang, Shuai Wang, Haining Tan, Pei Yang, Yuanyuan Li, Lingchuan Xu, Baoguo Duan, Yuhong Liu. Advances in polysaccharides of natural source of the anti-Alzheimer's disease effect and mechanism. Carbohydrate Polymers 2022; 296: 119961 doi: 10.1016/j.carbpol.2022.119961
|
10 |
Mitchell Thelen, Holly M. Brown-Borg. Does Diet Have a Role in the Treatment of Alzheimer's Disease?. Frontiers in Aging Neuroscience 2020; 12 doi: 10.3389/fnagi.2020.617071
|
11 |
Ting Yang, Yuhong Zhang, Lixuan Chen, Elizabeth Rosalind Thomas, Wenjing Yu, Bo Cheng, Xiang Li. The potential roles of ATF family in the treatment of Alzheimer's disease. Biomedicine & Pharmacotherapy 2023; 161: 114544 doi: 10.1016/j.biopha.2023.114544
|